Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Minnesota6


Florida6


New Jersey7


Iowa7


New York7


New Hampshire6


Wisconsin6


Connecticut7


Maine6


Pennsylvania6


Kentucky7


West Virginia6


South Dakota6


Nebraska6


Idaho7


Ohio6


Washington5


Illinois7


Massachusetts7


Kansas6


North Dakota6


Michigan6


Rhode Island6


Louisiana7


Vermont6


Missouri6


Arkansas6


Utah7


Oregon6


Maryland6


Montana6


Alaska6


California7


Delaware6


North Carolina6


Georgia7


Tennessee6


Texas7


Oklahoma6


Virginia6


Colorado6


Mississippi6


Wyoming6


South Carolina6


Alabama6


Hawaii7


Arizona6


District of Columbia6


New Mexico7


Puerto Rico6


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2024 7:20 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.